临床糖尿病肾病:自然史和并发症

A. Grenfell, P.J. Watkins
{"title":"临床糖尿病肾病:自然史和并发症","authors":"A. Grenfell,&nbsp;P.J. Watkins","doi":"10.1016/S0300-595X(86)80074-3","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>Diabetic nephropathy develops in about 45% of insulin dependent diabetics of whom two-thirds will develop renal failure, the rest dying from cardiovascular disease.</p></span></li><li><span>2.</span><span><p>Most of the excess mortality of insulin dependent diabetics occurs in those with proteinuria.</p></span></li><li><span>3.</span><span><p>Among non-insulin dependent diabetics nephropathy is also an important cause of increased mortality but this is mainly from cardiovascular disease.</p></span></li><li><span>4.</span><span><p>Once diabetic nephropathy is established it progresses relentlessly to end-stage renal failure over about seven years, but ranging from five to 20 years. The explanation for the different rates of progression in individual patients is not understood.</p></span></li><li><span>5.</span><span><p>Hypertension accompanies diabetic nephropathy and its treatment may retard the progression of renal failure.</p></span></li><li><span>6.</span><span><p>Other forms of intervention include glycaemic control which has not been shown to have any effect, and protein restriction for which no conclusions can be drawn at present.</p></span></li><li><span>7.</span><span><p>The diagnosis of diabetic nephropathy is straightforward in the presence of a typical history and clinical features. Non-diabetic renal disease is sometimes the cause of renal failure and may require specific treatment; prognosis for renal failure treatment may be better than for nephropathy patients with other diabetic complications.</p></span></li><li><span>8.</span><span><p>Other diabetic complications develop as diabetic nephropathy progresses, most notably cardiac and peripheral vascular disease. Proliferative retinopathy and neuropathy are considerable problems and their management needs attention both before and after renal failure treatment.</p></span></li></ul></div>","PeriodicalId":10454,"journal":{"name":"Clinics in Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1986-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0300-595X(86)80074-3","citationCount":"65","resultStr":"{\"title\":\"Clinical diabetic nephropathy: Natural history and complications\",\"authors\":\"A. Grenfell,&nbsp;P.J. Watkins\",\"doi\":\"10.1016/S0300-595X(86)80074-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p></p><ul><li><span>1.</span><span><p>Diabetic nephropathy develops in about 45% of insulin dependent diabetics of whom two-thirds will develop renal failure, the rest dying from cardiovascular disease.</p></span></li><li><span>2.</span><span><p>Most of the excess mortality of insulin dependent diabetics occurs in those with proteinuria.</p></span></li><li><span>3.</span><span><p>Among non-insulin dependent diabetics nephropathy is also an important cause of increased mortality but this is mainly from cardiovascular disease.</p></span></li><li><span>4.</span><span><p>Once diabetic nephropathy is established it progresses relentlessly to end-stage renal failure over about seven years, but ranging from five to 20 years. The explanation for the different rates of progression in individual patients is not understood.</p></span></li><li><span>5.</span><span><p>Hypertension accompanies diabetic nephropathy and its treatment may retard the progression of renal failure.</p></span></li><li><span>6.</span><span><p>Other forms of intervention include glycaemic control which has not been shown to have any effect, and protein restriction for which no conclusions can be drawn at present.</p></span></li><li><span>7.</span><span><p>The diagnosis of diabetic nephropathy is straightforward in the presence of a typical history and clinical features. Non-diabetic renal disease is sometimes the cause of renal failure and may require specific treatment; prognosis for renal failure treatment may be better than for nephropathy patients with other diabetic complications.</p></span></li><li><span>8.</span><span><p>Other diabetic complications develop as diabetic nephropathy progresses, most notably cardiac and peripheral vascular disease. Proliferative retinopathy and neuropathy are considerable problems and their management needs attention both before and after renal failure treatment.</p></span></li></ul></div>\",\"PeriodicalId\":10454,\"journal\":{\"name\":\"Clinics in Endocrinology and Metabolism\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1986-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0300-595X(86)80074-3\",\"citationCount\":\"65\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics in Endocrinology and Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0300595X86800743\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics in Endocrinology and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0300595X86800743","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 65

摘要

1.约45%的胰岛素依赖型糖尿病患者会发展为糖尿病肾病,其中三分之二会发展为肾衰竭,其余的则死于心血管疾病。大多数胰岛素依赖型糖尿病患者的超额死亡率发生在蛋白尿患者身上。在非胰岛素依赖型糖尿病患者中,肾病也是死亡率增加的一个重要原因,但这主要来自心血管疾病。一旦糖尿病肾病确立,它会持续发展到终末期肾功能衰竭,持续时间约为7年,但从5年到20年不等。个别病人的不同进展速度的原因尚不清楚。高血压合并糖尿病肾病,其治疗可延缓肾功能衰竭的进展。其他形式的干预包括控制血糖,但没有显示出任何效果,以及限制蛋白质,目前还没有结论。糖尿病肾病的诊断是直截了当的存在一个典型的历史和临床特征。非糖尿病性肾脏疾病有时是肾功能衰竭的原因,可能需要特殊治疗;肾功能衰竭治疗的预后可能比合并其他糖尿病并发症的肾病患者好。其他糖尿病并发症随着糖尿病肾病的进展而发展,最明显的是心脏和周围血管疾病。增殖性视网膜病变和神经病变是相当大的问题,其管理需要注意在肾功能衰竭治疗前后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinical diabetic nephropathy: Natural history and complications

  • 1.

    Diabetic nephropathy develops in about 45% of insulin dependent diabetics of whom two-thirds will develop renal failure, the rest dying from cardiovascular disease.

  • 2.

    Most of the excess mortality of insulin dependent diabetics occurs in those with proteinuria.

  • 3.

    Among non-insulin dependent diabetics nephropathy is also an important cause of increased mortality but this is mainly from cardiovascular disease.

  • 4.

    Once diabetic nephropathy is established it progresses relentlessly to end-stage renal failure over about seven years, but ranging from five to 20 years. The explanation for the different rates of progression in individual patients is not understood.

  • 5.

    Hypertension accompanies diabetic nephropathy and its treatment may retard the progression of renal failure.

  • 6.

    Other forms of intervention include glycaemic control which has not been shown to have any effect, and protein restriction for which no conclusions can be drawn at present.

  • 7.

    The diagnosis of diabetic nephropathy is straightforward in the presence of a typical history and clinical features. Non-diabetic renal disease is sometimes the cause of renal failure and may require specific treatment; prognosis for renal failure treatment may be better than for nephropathy patients with other diabetic complications.

  • 8.

    Other diabetic complications develop as diabetic nephropathy progresses, most notably cardiac and peripheral vascular disease. Proliferative retinopathy and neuropathy are considerable problems and their management needs attention both before and after renal failure treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Growth hormone neurosecretory dysfunction. Long-term complications of diabetes. Contributors to this issue Foreword The pathology of diabetic neuropathy and the effects of aldose reductase inhibitors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1